Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients
- PMID: 12765670
- DOI: 10.1016/s0261-5614(02)00234-0
Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients
Abstract
Aims: To determine whether a specific high-protein enteral formula with a similar caloric percentage of fat and carbohydrates achieves greater control over glycemic levels and reduces insulin requirements in hyperglycemic critically ill patients when compared to a control high-protein enteral formula.
Design: A prospective, randomized, controlled, single-blind trial in two University Hospital Intensive Care Units in Spain.
Methods: We enrolled 50 patients with diabetes mellitus or stress hyperglycemia with basal glycemia > or =160 mg/dl and indication for enteral nutrition > or =5 days. Patients with severe kidney failure, liver failure or obesity were excluded from the study. In the first 48 h of admission, after randomization, 26 patients received the study diet and 24 patients received the control diet. The variables were monitored for 14 days. The Harris-Benedict formula with a fixed stress factor of 1.2 was used to calculate caloric needs. Insulin was administered by continuous infusion. An intention-to-treat analysis was performed.
Results: On admission, there were no differences between the study and control group in plasma glucose levels (mg/dl) (190.9+/-45 vs 210.3+/-63) and capillary glucose levels (mg/dl) (226.1+/-73 vs 213.8+/-67). After the feeding trial, there were differences between the study and control group in plasma glucose levels (mg/dl) (176.8+/-44 vs 222.8+/-47, P=0.001), capillary glucose levels (mg/dl) (163.1+/-45 vs 216.4+/-56, P=0.001), insulin requirements/day (IU) 8.73 (2.3-27.5) vs 30.2 (21.5-57.1) (P=0.001), insulin/received carbohydrates (UI/g) 0.07 (0.02-0.22) vs 0.18 (0.11-0.35) (P=0.02) and insulin/received carbohydrates/kg 0.98 (0.26-3.59) vs 2.13 (1.44-4.58) (P=0.04). These differences remain in a day-to-day comparison. There were no differences in the analytical tests, or in digestive or infectious complications. Intensive Care Unit length of stay, mechanical ventilation and mortality were similar in both groups.
Conclusions: Hyperglycemic critically ill patients fed with a high-protein diet with a similar caloric percentage of fat and carbohydrates show a significant reduction in plasma glucose levels, capillary glucose levels and insulin requirements in comparison to patients on a conventional high-protein diet. This better glycemic control do not modify Intensive Care Unit length of stay, infectious complications, mechanical ventilation and mortality.
Similar articles
-
Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study.Crit Care. 2015 Nov 9;19:390. doi: 10.1186/s13054-015-1108-1. Crit Care. 2015. PMID: 26549276 Free PMC article. Clinical Trial.
-
Fat-Modified Enteral Formula Improves Feeding Tolerance in Critically Ill Patients: A Multicenter, Single-Blind, Randomized Controlled Trial.JPEN J Parenter Enteral Nutr. 2017 Jul;41(5):785-795. doi: 10.1177/0148607115601858. Epub 2015 Sep 8. JPEN J Parenter Enteral Nutr. 2017. PMID: 26350918 Clinical Trial.
-
Glycemic Effects of a Low-Carbohydrate Enteral Formula Compared With an Enteral Formula of Standard Composition in Critically Ill Patients: An Open-Label Randomized Controlled Clinical Trial.JPEN J Parenter Enteral Nutr. 2018 Aug;42(6):1035-1045. doi: 10.1002/jpen.1045. Epub 2017 Dec 27. JPEN J Parenter Enteral Nutr. 2018. PMID: 30133840 Clinical Trial.
-
[Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): hyperglycemia and diabetes mellitus].Med Intensiva. 2011 Nov;35 Suppl 1:48-52. doi: 10.1016/S0210-5691(11)70010-9. Med Intensiva. 2011. PMID: 22309753 Spanish.
-
Effects of high-fat, low-carbohydrate enteral nutrition in critically ill patients: A systematic review with meta-analysis.Clin Nutr. 2024 Oct;43(10):2399-2406. doi: 10.1016/j.clnu.2024.09.023. Epub 2024 Sep 12. Clin Nutr. 2024. PMID: 39288649
Cited by
-
Diabetes-Specific Formulae Versus Standard Formulae as Enteral Nutrition to Treat Hyperglycemia in Critically Ill Patients: Protocol for a Randomized Controlled Feasibility Trial.JMIR Res Protoc. 2018 Apr 9;7(4):e90. doi: 10.2196/resprot.9374. JMIR Res Protoc. 2018. PMID: 29631990 Free PMC article.
-
Carbohydrate provision in the era of tight glucose control.Curr Gastroenterol Rep. 2011 Aug;13(4):388-94. doi: 10.1007/s11894-011-0204-x. Curr Gastroenterol Rep. 2011. PMID: 21604041 Free PMC article. Review.
-
Classifying Enteral Nutrition: Tailored for Clinical Practice.Curr Gastroenterol Rep. 2019 Jul 31;21(9):47. doi: 10.1007/s11894-019-0708-3. Curr Gastroenterol Rep. 2019. PMID: 31368086 Review.
-
The effect of higher versus lower protein delivery in critically ill patients: a systematic review and meta-analysis of randomized controlled trials.Crit Care. 2021 Jul 23;25(1):260. doi: 10.1186/s13054-021-03693-4. Crit Care. 2021. PMID: 34301303 Free PMC article.
-
Therapeutic Properties and Use of Extra Virgin Olive Oil in Clinical Nutrition: A Narrative Review and Literature Update.Nutrients. 2022 Mar 31;14(7):1440. doi: 10.3390/nu14071440. Nutrients. 2022. PMID: 35406067 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical